These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17209537)

  • 1. Haematological considerations in patients with cyanotic congenital heart disease: a review.
    Auluck A; Manohar C
    Dent Update; 2006 Dec; 33(10):617-8, 620-2. PubMed ID: 17209537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual post-extraction hemorrhage in a cardiac patient: a case report.
    Auluck A; Pai KM; Bhat KS; Thoppil PS
    J Can Dent Assoc; 2004 Dec; 70(11):769-73. PubMed ID: 15588552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
    Zabala LM; Guzzetta NA
    Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematopoietic system in cyanotic congenital heart disease].
    Lewandowska K; Rachocka J
    Pol Tyg Lek; 1968 Dec; 23(51):1984-6. PubMed ID: 4883798
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the conjunctival microcirculation in adult patients with cyanotic congenital heart disease compared to healthy controls.
    Brennan PF; Jing M; McNeil AJ; Awuah A; Mailey J; Kelly B; Finlay DD; Blighe K; McLaughlin JAD; Nesbit MA; Trucco E; Lockhart CJ; Moore TCB; Spence MS
    Microvasc Res; 2021 Jul; 136():104167. PubMed ID: 33838207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Iron Status of Children with Cyanotic Congenital Heart Disease in Lagos, Nigeria.
    Itiola AY; Animasahun BA; Njokanma OF
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e345-e351. PubMed ID: 31897318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Bochsen L; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Sep; 167(5):2210-4. PubMed ID: 22727966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.
    Jensen AS; Johansson PI; Idorn L; Sørensen KE; Thilén U; Nagy E; Furenäs E; Søndergaard L
    Int J Cardiol; 2013 Aug; 167(4):1317-21. PubMed ID: 22578951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
    Oechslin E; Kiowski W; Schindler R; Bernheim A; Julius B; Brunner-La Rocca HP
    Circulation; 2005 Aug; 112(8):1106-12. PubMed ID: 16103236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.
    Rupa-Matysek J; Trojnarska O; Gil L; Szczepaniak-Chicheł L; Wojtasińska E; Tykarski A; Grajek S; Komarnicki M
    Int J Cardiol; 2016 Jan; 202():556-60. PubMed ID: 26447661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and complications of infective endocarditis in patients growing up with congenital heart disease.
    Knirsch W; Haas NA; Uhlemann F; Dietz K; Lange PE
    Int J Cardiol; 2005 May; 101(2):285-91. PubMed ID: 15882677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infective endocarditis prophylaxis in congenital heart disease].
    Di Filippo S
    Presse Med; 2017 Jun; 46(6 Pt 1):606-611. PubMed ID: 28576635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.
    Gralnick HR
    Lancet; 1970 Jun; 1(7658):1204-5. PubMed ID: 4192381
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
    Braun SL; Eicken A; Kaemmerer H
    Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden deterioration in the renal function of an African child with cyanotic congenital heart disease.
    Adedoyin OT; Afolabi JK
    J Natl Med Assoc; 2006 Feb; 98(2):287-9. PubMed ID: 16708519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic changes in children with cyanotic and acyanotic congenital heart disease.
    Goel M; Shome DK; Singh ZN; Bhattacharjee J; Khalil A
    Indian Heart J; 2000; 52(5):559-63. PubMed ID: 11256779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome in patients with cyanotic congenital heart disease.
    Martínez-Lavín M; Fonseca C; Amigo MC; Nava A; Reyes PA; Ruiz-Argüelles A
    Clin Exp Rheumatol; 1995; 13(4):489-91. PubMed ID: 7586782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic consequences of cyanotic congenital heart disease.
    Rao PS
    Indian J Pediatr; 1983; 50(406):479-87. PubMed ID: 6674196
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal impairment in patients with long-standing cyanotic congenital heart disease.
    Dittrich S; Haas NA; Bührer C; Müller C; Dähnert I; Lange PE
    Acta Paediatr; 1998 Sep; 87(9):949-54. PubMed ID: 9764889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death caused by native aortic valve thrombosis in an adult patient with a complex congenital cyanotic heart disease.
    Yalonetsky S; Aharonson D; Hirsh R; Lorber A
    Int J Cardiol; 2009 Jul; 136(1):e11-3. PubMed ID: 18635274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.